Search Within

Andrea Knezevic

Formats
  1. Journal Article (53)
  2. Meeting Abstract (53)
  3. Research Letter (1)
Groups
  1. Department of Medicine (94)
  2. Solid Tumor Oncology Division (76)
  3. Genitourinary Oncology Service (64)
  4. Weinberg Fellows (61)
  5. Epidemiology and Biostatistics (58)
  6. Biostatistics Service (49)

More Groups

People
  1. Darren Feldman (52)
  2. Robert Motzer (48)
  3. Martin Voss (39)
  4. Chung-Han Lee (33)
  5. Maria Carlo (31)
  6. Ritesh Kotecha (27)

More People

Years
  1. 2025 (9)
  2. 2024 (19)
  3. 2023 (12)
  4. 2022 (14)
  5. 2021 (8)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. Cancer (4)
  3. Clinical Genitourinary Cancer (4)
  4. Biology of Blood and Marrow Transplantation (3)
  5. Blood (3)
  6. Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (41)
  2. Elsevier Inc. (14)
  3. American Association for Cancer Research (7)
  4. Wiley Blackwell (7)
  5. Springer (6)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (107)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort
    Meeting Abstract

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Impact of treatment line on outcomes with salvage ipilimumab plus nivolumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; Knezevic, A.; Shah, N. J.; Carlo, M. I.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas
    Meeting Abstract

    Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia
    Journal Article

    Pawloski, K. R.; Christian, N.; Knezevic, A.; Wen, H. Y.; Van Zee, K. J.; Morrow, M.; Tadros, A. B.
    Breast Cancer Research and Treatment (2020)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Selecting node-positive patients for axillary downstaging with neoadjuvant chemotherapy
    Journal Article

    Montagna, G.; Mamtani, A.; Knezevic, A.; Brogi, E.; Barrio, A. V.; Morrow, M.
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
    Journal Article

    Jain, T.; Knezevic, A.; Pennisi, M.; Chen, Y.; Ruiz, J. D.; Purdon, T. J.; Devlin, S. M.; Smith, M.; Shah, G. L.; Halton, E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save